Abstract: A expandable panel assembly that provides an air barrier in a row of server racks in a data center or similar facility in spaces in the row that are not occupied by a server rack. The expandable panel assembly includes a base panel assembly and a slidable panel assembly. The base panel assembly and the slidable panel assembly are configured such that the slidable panel assembly can be slid along the base panel assembly between retracted (non-extended) and extended positions. The base panel assembly includes a channel member with first and second channels. The slidable panel assembly is slidably retained in one of those channels.

Abstract: An access floor panel that includes a base and a top plate on top of the base in a thickness direction of the access floor panel. The base includes at least one elongated slot having (1) a depth in the thickness direction, (2) a longitudinal axis in a first direction perpendicular to the thickness direction and (3) a slot opening in the top of the base in the thickness direction. The top plate has an elongated opening that is aligned with the slot opening of the at least one slot. The base and the top plate are configured such that a fastener assembly is received through the slot opening of the base and the elongated opening of top plate and retained within the slot to attach a structure to the access floor panel.

Abstract: Disclosed herein is a method of administering to a patient in need thereof a therapeutically effective amount of an extracellular thiol isomerase inhibitor compound to treat or prevent a disease or condition influenced by the activity of one or more extracellular thiol isomerases (e.g. protein disulfide isomerase, ERp5, ERp57, ERp72 and thioredoxin). The disease or condition includes arterial thrombosis, venous thrombosis, a thrombotic disease, a cancer, an infectious disease, a viral disease, an immune disorder, inflammation, a neurologic disease, and a neurodegenerative disorder.

Abstract: An access floor panel that includes a base and a top plate on top of the base in a thickness direction of the access floor panel. The base includes at least one elongated slot having (1) a depth in the thickness direction, (2) a longitudinal axis in a first direction perpendicular to the thickness direction and (3) a slot opening in the top of the base in the thickness direction. The top plate has an elongated opening that is aligned with the slot opening of the at least one slot. The base and the top plate are configured such that a fastener assembly is received through the slot opening of the base and the elongated opening of top plate and retained within the slot to attach a structure to the access floor panel.

Abstract: Disclosed are methods of treating, inhibiting, or preventing the development of, a food allergy in a patient by administering a therapeutically effective amount of a thiol isomerase inhibitor to a patient in need thereof. Also disclosed are methods for treatment of other allergic diseases and inflammatory diseases.

Abstract: Disclosed herein is a method of administering to a patient in need thereof a therapeutically effective amount of an extracellular thiol isomerase inhibitor compound to treat or prevent a disease or condition influenced by the activity of one or more extracellular thiol isomerases (e.g. protein disulfide isomerase, ERp5, ERp57, ERp72 and thioredoxin). The disease or condition includes arterial thrombosis, venous thrombosis, a thrombotic disease, a cancer, an infectious disease, a viral disease, an immune disorder, inflammation, a neurologic disease, and a neurodegenerative disorder.

Abstract: A hanging device and methods of making the hanging device are shown and described herein. The hanging device may be a hook or a hanging device. The hanging device comprises: a) a first outer liner; b) at least one inner layer; and c) a second outer liner. For the hanging device, the first outer liner is at least partially disposed on the at least one inner layer and the second outer liner is at least partially disposed on the at least one inner layer, and the first outer liner, the at least one inner layer, and the second outer liner are laminated together. The hanging device may be comprised of a biobased material and/or a recycled material. The hanging device may be biodegradable.

Abstract: Acoustophoretic devices are disclosed. The devices include a flow chamber, an ultrasonic transducer, a reflector, an inlet, a filtrate outlet, a concentrate outlet, and optionally a lipid collection trap. The ultrasonic transducer and reflector create a multi-dimensional acoustic standing wave in the flow chamber that traps and separates red blood cells and/or lipids from blood. Concentrated red blood cells can be recovered via the concentrate outlet, the lipids can be recovered via the lipid collection trap, and the remaining blood can be recovered via the filtrate outlet. Methods for separating blood components (e.g., red blood cells, lipids, platelets, white blood cells) from blood are also disclosed. The red blood cells can undergo washing with a solvent to remove undesired admixtures. Cryoprotectants can be added or removed from the blood.

Abstract: Disclosed are methods of treating, inhibiting, or preventing the development of, a food allergy in a patient by administering a therapeutically effective amount of a thiol isomerase inhibitor to a patient in need thereof. Also disclosed are methods for treatment of other allergic diseases and inflammatory diseases.

Abstract: Disclosed herein is a method of administering to a patient in need thereof a therapeutically effective amount of an extracellular thiol isomerase inhibitor compound to treat or prevent a disease or condition influenced by the activity of one or more extracellular thiol isomerases (e.g. protein disulfide isomerase, ERp5, ERp57, ERp72 and thioredoxin). The disease or condition includes arterial thrombosis, venous thrombosis, a thrombotic disease, a cancer, an infectious disease, a viral disease, an immune disorder, inflammation, a neurologic disease, and a neurodegenerative disorder.